Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol for Glucose Tolerance in CKD
NCT01003275Phase 2Completed
- Sponsor
- University of Washington
- Start
- Oct 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paricalcitol oral solution in glucose intolerance, sponsored by University of Washington. Started Oct 2009; status: completed.
02
Drugs
paricalcitol oral solution
03
Conditions
glucose intolerance
Beyond the preview
Go deeper on NCT01003275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01003275.